HomeALPMY • OTCMKTS
add
Astellas Pharma ADR Representing 1 Ord Shs
Previous close
$10.68
Day range
$10.72 - $10.80
Year range
$8.37 - $13.14
Market cap
2.88T JPY
Avg Volume
189.71K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (JPY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 505.79B | 6.91% |
Operating expense | 306.92B | -6.62% |
Net income | 68.42B | 81.96% |
Net profit margin | 13.53 | 70.19% |
Earnings per share | — | — |
EBITDA | 151.84B | 46.59% |
Effective tax rate | 24.33% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 215.40B | -28.89% |
Total assets | 3.34T | -10.70% |
Total liabilities | 1.85T | -9.96% |
Total equity | 1.48T | — |
Shares outstanding | 1.79B | — |
Price to book | 0.01 | — |
Return on assets | 7.79% | — |
Return on capital | 11.03% | — |
Cash Flow
Net change in cash
| (JPY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 68.42B | 81.96% |
Cash from operations | 54.84B | 335.21% |
Cash from investing | -16.74B | 57.44% |
Cash from financing | -11.04B | 7.36% |
Net change in cash | 27.03B | 182.50% |
Free cash flow | 9.85B | 191.42% |
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
13,643
